Australia · Delayed Price · Currency is AUD Cochlear Statistics
Total Valuation
Cochlear has a market cap or net worth of AUD 13.01 billion. The enterprise value is 13.07 billion.
| Market Cap | 13.01B |
| Enterprise Value | 13.07B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Mar 19, 2026 |
Share Statistics
Cochlear has 65.40 million shares outstanding. The number of shares has decreased by -0.17% in one year.
| Current Share Class | 65.40M |
| Shares Outstanding | 65.40M |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 62.87% |
| Float | 65.14M |
Valuation Ratios
The trailing PE ratio is 37.78 and the forward PE ratio is 29.92. Cochlear's PEG ratio is 2.01.
| PE Ratio | 37.78 |
| Forward PE | 29.92 |
| PS Ratio | 5.57 |
| PB Ratio | 6.72 |
| P/TBV Ratio | 9.08 |
| P/FCF Ratio | 64.69 |
| P/OCF Ratio | 49.21 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.89, with an EV/FCF ratio of 64.96.
| EV / Earnings | 37.85 |
| EV / Sales | 5.59 |
| EV / EBITDA | 21.89 |
| EV / EBIT | 26.01 |
| EV / FCF | 64.96 |
Financial Position
The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.46 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.20 |
| Interest Coverage | 43.40 |
Financial Efficiency
Return on equity (ROE) is 18.15% and return on invested capital (ROIC) is 19.15%.
| Return on Equity (ROE) | 18.15% |
| Return on Assets (ROA) | 11.28% |
| Return on Invested Capital (ROIC) | 19.15% |
| Return on Capital Employed (ROCE) | 22.53% |
| Weighted Average Cost of Capital (WACC) | 6.99% |
| Revenue Per Employee | 425,182 |
| Profits Per Employee | 62,782 |
| Employee Count | 5,500 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, Cochlear has paid 110.00 million in taxes.
| Income Tax | 110.00M |
| Effective Tax Rate | 24.16% |
Stock Price Statistics
The stock price has decreased by -25.05% in the last 52 weeks. The beta is 0.51, so Cochlear's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -25.05% |
| 50-Day Moving Average | 248.68 |
| 200-Day Moving Average | 279.37 |
| Relative Strength Index (RSI) | 24.67 |
| Average Volume (20 Days) | 214,838 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cochlear had revenue of AUD 2.34 billion and earned 345.30 million in profits. Earnings per share was 5.27.
| Revenue | 2.34B |
| Gross Profit | 1.70B |
| Operating Income | 503.40M |
| Pretax Income | 455.30M |
| Net Income | 345.30M |
| EBITDA | 562.00M |
| EBIT | 503.40M |
| Earnings Per Share (EPS) | 5.27 |
Balance Sheet
The company has 187.10 million in cash and 242.20 million in debt, with a net cash position of -55.10 million or -0.84 per share.
| Cash & Cash Equivalents | 187.10M |
| Total Debt | 242.20M |
| Net Cash | -55.10M |
| Net Cash Per Share | -0.84 |
| Equity (Book Value) | 1.94B |
| Book Value Per Share | 29.63 |
| Working Capital | 814.00M |
Cash Flow
In the last 12 months, operating cash flow was 264.50 million and capital expenditures -63.30 million, giving a free cash flow of 201.20 million.
| Operating Cash Flow | 264.50M |
| Capital Expenditures | -63.30M |
| Free Cash Flow | 201.20M |
| FCF Per Share | 3.08 |
Margins
Gross margin is 72.76%, with operating and profit margins of 21.53% and 14.77%.
| Gross Margin | 72.76% |
| Operating Margin | 21.53% |
| Pretax Margin | 19.47% |
| Profit Margin | 14.77% |
| EBITDA Margin | 24.03% |
| EBIT Margin | 21.53% |
| FCF Margin | 8.60% |
Dividends & Yields
This stock pays an annual dividend of 4.30, which amounts to a dividend yield of 2.16%.
| Dividend Per Share | 4.30 |
| Dividend Yield | 2.16% |
| Dividend Growth (YoY) | 1.18% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 81.47% |
| Buyback Yield | 0.17% |
| Shareholder Yield | 2.33% |
| Earnings Yield | 2.65% |
| FCF Yield | 1.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cochlear has an Altman Z-Score of 15.24 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.24 |
| Piotroski F-Score | 4 |